Literature DB >> 12533040

Primary myeloid sarcoma of the gynecologic tract: a report of two cases progressing to acute myeloid leukemia.

José-Angel Hernández1, José-Tomás Navarro, María Rozman, Josep-María Ribera, Montserrat Rovira, María-Alba Bosch, María-José Fantova, José-Luis Mate, Fuensanta Millá.   

Abstract

Primary gynecologic myeloid sarcomas are rare, and their diagnosis is often difficult. Differential diagnosis includes lymphomas and carcinomas of the gynecologic tract. We report the clinical, morphological, immunohistochemical and cytogenetic features of two cases of chloromas of the female genital tract, which progressed to acute myeloid leukemia in spite of aggressive therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12533040     DOI: 10.1080/1042819021000016096

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  Postmenopausal bleeding as first sign of an acute myelogenous leukaemia: A case report and review of the literature.

Authors:  M Henes; A Nauth; A Staebler; S Becker; J C Henes
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

2.  Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus.

Authors:  Vinod Pullarkat; Leslie Veliz; Karen Chang; Ann Mohrbacher; Anna Lizza Teotico; Stephen J Forman; Marilyn L Slovak
Journal:  J Clin Pathol       Date:  2007-05       Impact factor: 3.411

3.  The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report.

Authors:  Aleksina Shatilova; Larisa Girshova; Daniil Zaytsev; Irina Budaeva; Yuliya Mirolyubova; Darya Ryzhkova; Roman Grozov; Konstantin Bogdanov; Tatiana Nikulina; Dmitriy Motorin; Darina Zammoeva; Svetlana Efremova; Vladimir Ivanov; Alexey Petukhov; Yuliya Alekseeva; Andrey Zaritskey
Journal:  BMC Womens Health       Date:  2021-05-01       Impact factor: 2.742

4.  Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review.

Authors:  Yuan Yu; Xuemei Qin; Shuxin Yan; Wenxia Wang; Yanlin Sun; Maohong Zhang
Journal:  Onco Targets Ther       Date:  2015-12-10       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.